Clinical Trial Update: Safety and Efficacy of Apixaban Versus Warfarin in Peritoneal Dialysis Patients With Non Valvular Atrial Fibrillation: a Prospective, Randomised, Open-label, Blinded End-point Trial (APIDP2) [Phase 3]

View source ↗

Summary

Phase 3 prospective randomized trial comparing apixaban with warfarin in non-valvular atrial fibrillation patients on peritoneal dialysis; the study is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• End-stage Renal Disease

Drugs mentioned

• Coumadin (warfarin)
• Eliquis (apixaban)

Snippet

Sponsor: University Hospital, Caen | Conditions: Atrial Fibrillation, Peritoneal Dialysis Complication | Phase 3 | Status: NOT_YET_RECRUITING